Here, we used rat and mouse orthotopic tumor models to further evaluate the safety of brain rTMS and determine whether an rTMS-induced increase in IGF-Trap delivery to the brain could inhibit the growth of intra-cerebrally implanted brain tumors. This evidence concerns the gene IGF1 and neoplasm.